272 related articles for article (PubMed ID: 21945652)
21. Dopamine modulates the function of group II and group III metabotropic glutamate receptors in the substantia nigra pars reticulata.
Wittmann M; Marino MJ; Conn PJ
J Pharmacol Exp Ther; 2002 Aug; 302(2):433-41. PubMed ID: 12130700
[TBL] [Abstract][Full Text] [Related]
22. Cannabinoids inhibit excitatory neurotransmission in the substantia nigra pars reticulata.
Szabo B; Wallmichrath I; Mathonia P; Pfreundtner C
Neuroscience; 2000; 97(1):89-97. PubMed ID: 10771342
[TBL] [Abstract][Full Text] [Related]
23. The role of NMDA receptors in regulating group II metabotropic glutamate receptor-mediated long-term depression in rat medial prefrontal cortex.
Huang CC; Hsu KS
Neuropharmacology; 2008 Jun; 54(7):1071-8. PubMed ID: 18378263
[TBL] [Abstract][Full Text] [Related]
24. Modulation of stress-induced and stimulated hyperprolactinemia with the group II metabotropic glutamate receptor selective agonist, LY379268.
Johnson MP; Chamberlain M
Neuropharmacology; 2002 Oct; 43(5):799-808. PubMed ID: 12384165
[TBL] [Abstract][Full Text] [Related]
25. Activation of synaptic group II metabotropic glutamate receptors induces long-term depression at GABAergic synapses in CNS neurons.
Tang ZQ; Liu YW; Shi W; Dinh EH; Hamlet WR; Curry RJ; Lu Y
J Neurosci; 2013 Oct; 33(40):15964-77. PubMed ID: 24089501
[TBL] [Abstract][Full Text] [Related]
26. Subthalamic stimulation evokes complex EPSCs in the rat substantia nigra pars reticulata in vitro.
Shen KZ; Johnson SW
J Physiol; 2006 Jun; 573(Pt 3):697-709. PubMed ID: 16613871
[TBL] [Abstract][Full Text] [Related]
27. Antagonists reversibly reverse chemical LTD induced by group I, group II and group III metabotropic glutamate receptors.
Lodge D; Tidball P; Mercier MS; Lucas SJ; Hanna L; Ceolin L; Kritikos M; Fitzjohn SM; Sherwood JL; Bannister N; Volianskis A; Jane DE; Bortolotto ZA; Collingridge GL
Neuropharmacology; 2013 Nov; 74():135-46. PubMed ID: 23542080
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobicyclo[3.1.0] hexane-2,6-dicarboxylic acid (LY354740): identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptors.
Monn JA; Valli MJ; Massey SM; Hansen MM; Kress TJ; Wepsiec JP; Harkness AR; Grutsch JL; Wright RA; Johnson BG; Andis SL; Kingston A; Tomlinson R; Lewis R; Griffey KR; Tizzano JP; Schoepp DD
J Med Chem; 1999 Mar; 42(6):1027-40. PubMed ID: 10090786
[TBL] [Abstract][Full Text] [Related]
29. The potent, selective mGlu2/3 receptor agonist LY379268 increases extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid, homovanillic acid, and 5-hydroxyindole-3-acetic acid in the medial prefrontal cortex of the freely moving rat.
Cartmell J; Perry KW; Salhoff CR; Monn JA; Schoepp DD
J Neurochem; 2000 Sep; 75(3):1147-54. PubMed ID: 10936197
[TBL] [Abstract][Full Text] [Related]
30. Activation of mGlu3 receptors stimulates the production of GDNF in striatal neurons.
Battaglia G; Molinaro G; Riozzi B; Storto M; Busceti CL; Spinsanti P; Bucci D; Di Liberto V; Mudò G; Corti C; Corsi M; Nicoletti F; Belluardo N; Bruno V
PLoS One; 2009 Aug; 4(8):e6591. PubMed ID: 19672295
[TBL] [Abstract][Full Text] [Related]
31. Group II metabotropic glutamate receptor modulation of DOI-induced c-fos mRNA and excitatory responses in the cerebral cortex.
Zhai Y; George CA; Zhai J; Nisenbaum ES; Johnson MP; Nisenbaum LK
Neuropsychopharmacology; 2003 Jan; 28(1):45-52. PubMed ID: 12496939
[TBL] [Abstract][Full Text] [Related]
32. A selective allosteric potentiator of metabotropic glutamate (mGlu) 2 receptors has effects similar to an orthosteric mGlu2/3 receptor agonist in mouse models predictive of antipsychotic activity.
Galici R; Echemendia NG; Rodriguez AL; Conn PJ
J Pharmacol Exp Ther; 2005 Dec; 315(3):1181-7. PubMed ID: 16123306
[TBL] [Abstract][Full Text] [Related]
33. Presynaptic inhibition of corticothalamic feedback by metabotropic glutamate receptors.
Alexander GM; Godwin DW
J Neurophysiol; 2005 Jul; 94(1):163-75. PubMed ID: 15772234
[TBL] [Abstract][Full Text] [Related]
34. Metabotropic glutamate 2 receptors modulate synaptic inputs and calcium signals in striatal cholinergic interneurons.
Pisani A; Bonsi P; Catania MV; Giuffrida R; Morari M; Marti M; Centonze D; Bernardi G; Kingston AE; Calabresi P
J Neurosci; 2002 Jul; 22(14):6176-85. PubMed ID: 12122076
[TBL] [Abstract][Full Text] [Related]
35. Modulation of GABAergic inhibition in the rat superior colliculus by a presynaptic group II metabotropic glutamate receptor.
Neale SA; Salt TE
J Physiol; 2006 Dec; 577(Pt 2):659-69. PubMed ID: 16973709
[TBL] [Abstract][Full Text] [Related]
36. Activation of group II metabotropic glutamate receptors inhibits synaptic excitation of the substantia Nigra pars reticulata.
Bradley SR; Marino MJ; Wittmann M; Rouse ST; Awad H; Levey AI; Conn PJ
J Neurosci; 2000 May; 20(9):3085-94. PubMed ID: 10777772
[TBL] [Abstract][Full Text] [Related]
37. mGlu2 metabotropic glutamate receptors restrain inflammatory pain and mediate the analgesic activity of dual mGlu2/mGlu3 receptor agonists.
Zammataro M; Chiechio S; Montana MC; Traficante A; Copani A; Nicoletti F; Gereau RW
Mol Pain; 2011 Jan; 7():6. PubMed ID: 21235748
[TBL] [Abstract][Full Text] [Related]
38. Differential regulation of synaptic transmission by mGlu2 and mGlu3 at the perforant path inputs to the dentate gyrus and CA1 revealed in mGlu2 -/- mice.
Kew JN; Pflimlin MC; Kemp JA; Mutel V
Neuropharmacology; 2002 Aug; 43(2):215-21. PubMed ID: 12213275
[TBL] [Abstract][Full Text] [Related]
39. Involvement of group I metabotropic glutamate receptors and glutamate transporters in the slow excitatory synaptic transmission in the spinal cord dorsal horn.
Galik J; Youn DH; Kolaj M; Randić M
Neuroscience; 2008 Jul; 154(4):1372-87. PubMed ID: 18554818
[TBL] [Abstract][Full Text] [Related]
40. Evidence for the role of metabotropic glutamate (mGlu)2 not mGlu3 receptors in the preclinical antipsychotic pharmacology of the mGlu2/3 receptor agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic acid (LY404039).
Fell MJ; Svensson KA; Johnson BG; Schoepp DD
J Pharmacol Exp Ther; 2008 Jul; 326(1):209-17. PubMed ID: 18424625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
